Accessibility Menu
Arrow-Thin-Down
S&P 500
6,716.09
+0.2%
+16.71
Arrow-Thin-Down
DJI
46,993.26
+0.1%
+46.85
Arrow-Thin-Down
NASDAQ
22,479.53
+0.5%
+105.35
Arrow-Thin-Down
Bitcoin
$74,342.00
-0.4%
-$300.98
Arrow-Thin-Down
AMZN
$215.20
+1.6%
+$3.46
Arrow-Thin-Down
GOOG
$309.41
+1.6%
+$4.99
Arrow-Thin-Down
META
$622.43
-0.8%
-$5.02
Arrow-Thin-Down
MSFT
$399.44
-0.1%
-$0.51
Arrow-Thin-Down
NVDA
$181.86
-0.7%
-$1.36
Arrow-Thin-Down
TSLA
$399.27
+0.9%
+$3.71
Most Active StocksDaily Stock GainersDaily Stock Losers

Foolish Preview: Gilead Earnings

A look ahead at what we can expect from Gilead.

By Dave Williamson – Jan 31, 2013 at 5:51PM EST

Gilead (GILD 0.57%) will be reporting 4Q earnings on Monday, as well as the company's full 2012 results. In this video, Motley Fool health-care analyst David Williamson tells us why it has been a transformational year for the company, and what  key things to watch for in the upcoming earnings report.

Read Next

About the Author

Dave Williamson
The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...
XMFGreenwave4
X@motleydavid

Stocks Mentioned

Gilead Sciences Stock Quote
Gilead Sciences
NASDAQ: GILD
$144.38
(-0.57%)-$0.83
Johnson & Johnson Stock Quote
Johnson & Johnson
NYSE: JNJ
$238.11
(-2.09%)-$5.08
AbbVie Stock Quote
AbbVie
NYSE: ABBV
$219.83
(-0.73%)-$1.62

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services